Outpatient parenteral antifungal therapy (OPAT) for invasive fungal infections with intermittent dosing of liposomal amphotericin B

Triazole resistant A. fumigatus has been documented in many parts of the world. In the Netherlands, incidence is now above 10% and results in the need for long-term parenteral therapy with liposomal amphotericin B (LAmB). The long terminal half-life of LAmB suggests that intermittent dosing could be...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Med Mycol
Main Authors: van de Peppel, Robert J, Schauwvlieghe, Alexander, Van Daele, Ruth, Spriet, Isabel, van't Wout, Jan W, Brüggemann, Roger J, Rijnders, Bart J A, Hendriks, Bart J C, de Boer, Mark G J
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7527269/
https://ncbi.nlm.nih.gov/pubmed/31965178
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/mmy/myz134
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados